GB2212511B - Hepatitis c virus - Google Patents
Hepatitis c virusInfo
- Publication number
- GB2212511B GB2212511B GB8827024A GB8827024A GB2212511B GB 2212511 B GB2212511 B GB 2212511B GB 8827024 A GB8827024 A GB 8827024A GB 8827024 A GB8827024 A GB 8827024A GB 2212511 B GB2212511 B GB 2212511B
- Authority
- GB
- United Kingdom
- Prior art keywords
- hepatitis
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241000711549 Hepacivirus C Species 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
- C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Virology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12271487A | 1987-11-18 | 1987-11-18 | |
| US13988687A | 1987-12-30 | 1987-12-30 | |
| US16107288A | 1988-02-26 | 1988-02-26 | |
| US19126388A | 1988-05-06 | 1988-05-06 | |
| US26358488A | 1988-10-26 | 1988-10-26 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| GB8827024D0 GB8827024D0 (en) | 1988-12-21 |
| GB2212511A GB2212511A (en) | 1989-07-26 |
| GB2212511B true GB2212511B (en) | 1992-01-22 |
Family
ID=27537644
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB8827024A Expired - Lifetime GB2212511B (en) | 1987-11-18 | 1988-11-18 | Hepatitis c virus |
Country Status (3)
| Country | Link |
|---|---|
| GB (1) | GB2212511B (en) |
| SG (1) | SG102092G (en) |
| YU (1) | YU48038B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7049428B1 (en) | 1998-03-04 | 2006-05-23 | Washington University | HCV variants |
| US7070790B1 (en) | 1993-06-29 | 2006-07-04 | The United States Of America As Represented By The Department Of Health And Human Services | Nucleotide and deduced amino acid sequences of the envelope 1 and core genes of isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines |
| US7241879B2 (en) | 2000-06-15 | 2007-07-10 | Novartis Vaccines And Diagnostics, Inc. | Immunoassays for anti-HCV antibodies |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6171782B1 (en) | 1987-11-18 | 2001-01-09 | Chiron Corporation | Antibody compositions to HCV and uses thereof |
| US5714596A (en) * | 1987-11-18 | 1998-02-03 | Chiron Corporation | NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus |
| US5350671A (en) * | 1987-11-18 | 1994-09-27 | Chiron Corporation | HCV immunoassays employing C domain antigens |
| US5698390A (en) | 1987-11-18 | 1997-12-16 | Chiron Corporation | Hepatitis C immunoassays |
| US5712088A (en) * | 1987-11-18 | 1998-01-27 | Chiron Corporation | Methods for detecting Hepatitis C virus using polynucleotides specific for same |
| US5683864A (en) * | 1987-11-18 | 1997-11-04 | Chiron Corporation | Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies |
| US6861212B1 (en) | 1987-11-18 | 2005-03-01 | Chiron Corporation | NANBV diagnostics and vaccines |
| US6027729A (en) * | 1989-04-20 | 2000-02-22 | Chiron Corporation | NANBV Diagnostics and vaccines |
| FI906208A7 (en) | 1989-12-18 | 1991-06-19 | The Wellcome Foundation Ltd | Viral agents |
| US7166287B1 (en) | 1989-12-18 | 2007-01-23 | Glaxo Wellcome Inc. | Viral agent |
| US5712087A (en) * | 1990-04-04 | 1998-01-27 | Chiron Corporation | Immunoassays for anti-HCV antibodies employing combinations of hepatitis C virus (HCV) antigens |
| US6194140B1 (en) * | 1990-04-04 | 2001-02-27 | Chiron Corporation | HCV NS3 protein fragments having helicase activity and improved solubility |
| US6172189B1 (en) * | 1990-08-24 | 2001-01-09 | Abbott Laboratories | Hepatitis C assay utilizing recombinant antigens |
| ES2098511T3 (en) * | 1991-03-26 | 1997-05-01 | Dade Int Inc | DIAGNOSIS PROCEDURE FOR HEPATITIS NO-A NO-B. |
| US5574132A (en) * | 1991-04-05 | 1996-11-12 | Biochem Immunosystems Inc. | Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV) |
| WO1993000365A2 (en) * | 1991-06-24 | 1993-01-07 | Chiron Corporation | Hepatitis c virus (hcv) polypeptides |
| WO1993015193A1 (en) * | 1992-01-31 | 1993-08-05 | Abbott Laboratories | Mammalian expression systems for hcv proteins |
| US6620414B2 (en) | 1992-03-27 | 2003-09-16 | Smithkline Beecham Biologicals (S.A.) | Hepatitis vaccines containing 3-0-deacylated monophoshoryl lipid A |
| US5514539A (en) * | 1993-06-29 | 1996-05-07 | The United States Of America As Represented By The Department Of Health And Human Services | Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines |
| US5610009A (en) * | 1994-01-28 | 1997-03-11 | Abbott Laboratories | Mammalian expression systems for hepatitis C virus envelope genes |
| BR9506059A (en) * | 1994-07-29 | 1997-10-28 | Innogenetics Nv | Virus c purified envelope proteins for diagnostic and therapeutic use |
| US6107027A (en) * | 1994-12-14 | 2000-08-22 | University Of Washington | Ribozymes for treating hepatitis C |
| US6127116A (en) * | 1995-08-29 | 2000-10-03 | Washington University | Functional DNA clone for hepatitis C virus (HCV) and uses thereof |
| US7338759B1 (en) | 1997-03-04 | 2008-03-04 | Washington University | HCV variants |
| EP3313863B1 (en) * | 2015-06-29 | 2020-12-23 | The Board of Trustees of the Leland Stanford Junior University | Degron fusion constructs and methods for controlling protein production |
| CN107286237B (en) * | 2017-08-07 | 2020-04-03 | 广州泰诺迪生物科技有限公司 | Acquisition and application of an anti-hepatitis C virus antibody |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1982000205A1 (en) * | 1980-07-09 | 1982-01-21 | Baxter Travenol Lab | Non-a,non-b hepatitis assay and vaccine |
| WO1982002774A1 (en) * | 1981-02-11 | 1982-08-19 | Baxter Travenol Lab | Non-a,non-b hepatitis virus |
| EP0061974A2 (en) * | 1981-03-27 | 1982-10-06 | Institut Merieux | New vaccine and therapy against non-A non-B viral hepatitis, and their preparation process |
| WO1982003330A1 (en) * | 1981-03-30 | 1982-10-14 | Christian Trepo | Method for the preparation of antigens of the viral hepatitis nanb,and application to the preparation of a reaction agent allowing the diagnostic and pronostic of infections caused by the viruses of viral hepatitis |
| WO1988003410A1 (en) * | 1986-11-07 | 1988-05-19 | Pasteur Institut | Viral agent for nanb hepatitis, antigen and immunologic reagent |
| US4895976A (en) * | 1988-05-23 | 1990-01-23 | E. I. Du Pont De Nemours And Company | Preparation of 4-pentanoates by isomerization |
-
1988
- 1988-11-18 YU YU213888A patent/YU48038B/en unknown
- 1988-11-18 GB GB8827024A patent/GB2212511B/en not_active Expired - Lifetime
-
1992
- 1992-10-07 SG SG102092A patent/SG102092G/en unknown
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1982000205A1 (en) * | 1980-07-09 | 1982-01-21 | Baxter Travenol Lab | Non-a,non-b hepatitis assay and vaccine |
| WO1982002774A1 (en) * | 1981-02-11 | 1982-08-19 | Baxter Travenol Lab | Non-a,non-b hepatitis virus |
| EP0061974A2 (en) * | 1981-03-27 | 1982-10-06 | Institut Merieux | New vaccine and therapy against non-A non-B viral hepatitis, and their preparation process |
| WO1982003330A1 (en) * | 1981-03-30 | 1982-10-14 | Christian Trepo | Method for the preparation of antigens of the viral hepatitis nanb,and application to the preparation of a reaction agent allowing the diagnostic and pronostic of infections caused by the viruses of viral hepatitis |
| WO1988003410A1 (en) * | 1986-11-07 | 1988-05-19 | Pasteur Institut | Viral agent for nanb hepatitis, antigen and immunologic reagent |
| EP0277437A1 (en) * | 1986-11-07 | 1988-08-10 | Institut Pasteur | Hepatitis NANB viral agent, antigen and immunological reagent |
| US4895976A (en) * | 1988-05-23 | 1990-01-23 | E. I. Du Pont De Nemours And Company | Preparation of 4-pentanoates by isomerization |
Non-Patent Citations (6)
| Title |
|---|
| Chiron News Release 1988, May 10, 21 Lancet 1978, 21 October, 8095 * |
| Gastroenteralogy 1979,77(5),A33 (30th Annual Meeting of the American Association for the study of li * |
| Immun. Infect. 1988, 16(3), 91-96 * |
| Immun. Infect. 1988, 16(3), 97-99 * |
| Naturwissenschaften 1986, 73(1)45-46 * |
| ver disease, Chicago, Ill., USA, Nov. 7, 1979) Postgrad. Med. USA 1980, 68(5), 66-86 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7070790B1 (en) | 1993-06-29 | 2006-07-04 | The United States Of America As Represented By The Department Of Health And Human Services | Nucleotide and deduced amino acid sequences of the envelope 1 and core genes of isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines |
| US7049428B1 (en) | 1998-03-04 | 2006-05-23 | Washington University | HCV variants |
| US7241879B2 (en) | 2000-06-15 | 2007-07-10 | Novartis Vaccines And Diagnostics, Inc. | Immunoassays for anti-HCV antibodies |
Also Published As
| Publication number | Publication date |
|---|---|
| GB2212511A (en) | 1989-07-26 |
| YU213888A (en) | 1991-02-28 |
| YU48038B (en) | 1996-10-18 |
| GB8827024D0 (en) | 1988-12-21 |
| SG102092G (en) | 1992-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2212511B (en) | Hepatitis c virus | |
| GB9027250D0 (en) | Viral agent | |
| DK213987A (en) | HEPATITIS B-PEPTID DIMMUNOGEN | |
| GB8827619D0 (en) | Prolellor shroud | |
| IL79740A0 (en) | Hepatitis vaccine | |
| GB8711186D0 (en) | Wheelbarrow | |
| GB8704733D0 (en) | Wheelbarrow | |
| GB2200242B (en) | Magnetrons | |
| GB2181434A (en) | Hepatitis b virus vaccine and process for its preparation | |
| GB2193032B (en) | Magnetrons | |
| GB8621578D0 (en) | Hepatitis b viral antigens | |
| IE891804L (en) | Nonhyperglycosylated hepatitis b virus proteins | |
| GB8709817D0 (en) | Virus traps | |
| GB8712042D0 (en) | Virus & vaccine | |
| GB8406901D0 (en) | Virus vaccine | |
| GB9124696D0 (en) | Hepatitis c virus | |
| GB8515313D0 (en) | Hepatitis b treatment | |
| GB8704274D0 (en) | Hepatitis b diagnosis | |
| GB8608991D0 (en) | Virus vaccine | |
| GR3003377T3 (en) | Virus vaccine | |
| IE892907L (en) | Viral vaccines | |
| GB2207549B (en) | Magnetrons | |
| IE870224L (en) | Anti viral combination | |
| GB8509343D0 (en) | Virus vaccine | |
| GB8613616D0 (en) | Wheelbarrows |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 732 | Registration of transactions, instruments or events in the register (sect. 32/1977) | ||
| 775B | Specification amended (sect. 75/1977) | ||
| SP | Amendment (slips) printed | ||
| 775L | Amendment of patent in infringement or revocation proceedings. application to amend not proceeded with (sect. 75/1977) | ||
| SP | Amendment (slips) printed | ||
| SP | Amendment (slips) printed | ||
| PE20 | Patent expired after termination of 20 years |
Expiry date: 20081117 |